Key information is needed for excipients and their potential impact on continuous manufacturing processes.
Katherine L. Ulman
Advertisement
Katherine L. Ulman is president of KLU Consulting.
Articles by Katherine L. Ulman
Increasingly stringent audit requirements will make third-party accredited GMP audits critical for pharmaceutical excipients and raw materials.
Advertisement
Latest Updated Articles
Understanding Excipient Characteristics to Ensure Robust Continuous ManufacturingPublished: June 13th 2024 | Updated:
Third-Party Audits: Ensuring That Excipients Meet cGMP RequirementsPublished: September 1st 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
2
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
3
Standardizing Operations to Meet Global Sustainability and Resilience Goals
4
The Bio/pharma Industry Navigates AI’s Impact on Workforce and Hiring
5
